Your browser doesn't support javascript.
loading
Which adjuvant treatment for patients with BRAFV600-mutant cutaneous melanoma?
Funck-Brentano, E; Malissen, N; Roger, A; Lebbé, C; Deilhes, F; Frénard, C; Dréno, B; Meyer, N; Grob, J-J; Tétu, P; Saiag, P.
Affiliation
  • Funck-Brentano E; Department of General and Oncologic Dermatology, Ambroise-Paré hospital, AP-HP, Boulogne-Billancourt, France; Research unit EA4340 "Biomarkers and clinical trials in oncology and onco-hematology", Versailles-Saint-Quentin-en-Yvelines University, Paris-Saclay University, France. Electronic address: e
  • Malissen N; Department of Dermatology and Skin Cancer, Aix-Marseille University, AP-HM, Hôpital Timone, Marseille, France.
  • Roger A; Department of General and Oncologic Dermatology, Ambroise-Paré hospital, AP-HP, Boulogne-Billancourt, France; Research unit EA4340 "Biomarkers and clinical trials in oncology and onco-hematology", Versailles-Saint-Quentin-en-Yvelines University, Paris-Saclay University, France.
  • Lebbé C; Inserm U976, Department of Dermatology, Dermatology, Paris University, Hôpital Saint-Louis, AP-HP, Paris, France.
  • Deilhes F; Dermatology Department, CHU de Toulouse, Toulouse, France.
  • Frénard C; Department of Dermatology, CRCINA, CIC1413, CHU de Nantes, université de Nantes, Nantes, France.
  • Dréno B; Department of Dermatology, CRCINA, CIC1413, CHU de Nantes, université de Nantes, Nantes, France.
  • Meyer N; Dermatology Department, CHU de Toulouse, Toulouse, France.
  • Grob JJ; Department of Dermatology and Skin Cancer, Aix-Marseille University, AP-HM, Hôpital Timone, Marseille, France.
  • Tétu P; Department of Dermatology, CRCINA, CIC1413, CHU de Nantes, université de Nantes, Nantes, France.
  • Saiag P; Department of General and Oncologic Dermatology, Ambroise-Paré hospital, AP-HP, Boulogne-Billancourt, France; Research unit EA4340 "Biomarkers and clinical trials in oncology and onco-hematology", Versailles-Saint-Quentin-en-Yvelines University, Paris-Saclay University, France.
Ann Dermatol Venereol ; 148(3): 145-155, 2021 Sep.
Article in En | MEDLINE | ID: mdl-33579557

Full text: 1 Database: MEDLINE Main subject: Skin Neoplasms / Melanoma Limits: Humans Language: En Year: 2021 Type: Article

Full text: 1 Database: MEDLINE Main subject: Skin Neoplasms / Melanoma Limits: Humans Language: En Year: 2021 Type: Article